4
Changes in Ownership
Starling Oncology, Inc. Filed Acc 0001079973-26-001175
Director sold 298,853 shares at $6.51 ($1,946,310)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Hively Brad · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-08-21 | Sale : show line 1 in the form 10b5-1 | −298,853 | $6.51 | $1,946,310 | 411,976 | D |
| Open-market sales · 298,853 sh · avg $6.51 · $1,946,310 | ||||||
Loading xslF345X06/ownership.xml…